We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Intrauterine devices or IUDs rank second, behind coronary stents, in the adverse event report list of medical devices for 2018 which is being compiled and analysed by the Indian Pharmacopoeia Commission (IPC)....
Since the National Institute for Health and Care Excellence took the reins of England’s Cancer Drugs Fund last year, several drugmakers have seen their oncology meds get the boot. Not Bayer.